Clinical Trials for Polymun Scientific

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Polymun Scientific

Clinical Trials (2)

NCT05983874
A Study to Evaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, Given to a Population of Adults Who Have Received 3 Doses of 300µg BG505 SOSIP.GT1.1 gp140 Vaccine, Adjuvanted
PHASE1Enrolling by invitation
8 participants
Started: Apr 16, 2024 · Completed: Mar 31, 2025
1 condition4 sponsors1 location
NCT05772286
Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected Adults
PHASE1Active, not recruiting
12 participants
Started: Jul 24, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location